Stocks Health care PLSH
OTC · Health carePanacea Life Sciences Holdings, Inc. (PLSH)
Panacea Life Sciences Holdings, Inc. brought in $2.8M of revenue over the twelve months to March 31, 2024, up 50.4% from a year earlier. It posted a net loss of $7.7M. In fiscal 2023 capital spending exceeded operating cash flow by $1.6M. At March 31, 2024 it held $107.6K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 6, 2024.
Watch PLSH in 60 secondsWhat Panacea Life Sciences Holdings, Inc. does
Panacea Life Sciences Holdings, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker PLSH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2023 | $2.4M | -$8M | -$0.48 | -$1.6M |
| 2022 | $1.6M | -$9.1M | -$0.62 | -$2.6M |
| 2021 | $2.1M | -$4.8M | -$0.27 | -$4.1M |
| 2020 | $9M | -$5.2M | -$0.31 | -$10.8M |
| 2019 | $345.7K | -$10M | -$0.42 | -$6.3M |
| 2018 | $0 | -$4.3M | -$1.28 | -$465.8K |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Panacea Life Sciences Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- May 9, 2025Form SEC STAFF ACTION filing SEC STAFF ACTION
- July 16, 2024Deregistration 15-12G
- June 11, 2024Form 1-A filing 1-A
- May 16, 2024
- May 7, 2024Auditor change 8-K
- May 6, 2024Quarterly report 10-Q · period to March 31, 2024Revenue rose 56% to $1.1M versus the same quarter last year; diluted EPS -$0.09 versus -$0.12.
- April 1, 2024Annual report 10-K · period to December 31, 2023Revenue rose 47% to $2.4M versus the prior year; diluted EPS -$0.48 versus -$0.62.
- March 7, 2024
- February 5, 2024
- December 8, 2023
Questions about PLSH
What does Panacea Life Sciences Holdings, Inc. do?
Panacea Life Sciences Holdings, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker PLSH.
Is Panacea Life Sciences Holdings, Inc. profitable?
No. Over the twelve months to March 31, 2024 it reported a net loss of $7.7M on revenue of $2.8M.
How much revenue does Panacea Life Sciences Holdings, Inc. make?
Over the twelve months to March 31, 2024 Panacea Life Sciences Holdings, Inc. reported revenue of $2.8M. That is 50.4% more than a year earlier.
When did Panacea Life Sciences Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 6, 2024. It covers the period to March 31, 2024. Its newest filing of any kind is the form SEC STAFF ACTION filing from May 9, 2025.
Similar companies
Compare PLSH with
Follow PLSH
Get an email when Panacea Life Sciences Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PLSH: get an email when it filesWhere the numbers come from
Financial figures are the values Panacea Life Sciences Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.